| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |